Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 67

1.

Effectiveness of an internet intervention (Deprexis) for depression in a united states adult sample: A parallel-group pragmatic randomized controlled trial.

Beevers CG, Pearson R, Hoffman JS, Foulser AA, Shumake J, Meyer B.

J Consult Clin Psychol. 2017 Apr;85(4):367-380. doi: 10.1037/ccp0000171. Epub 2017 Feb 23.

PMID:
28230390
2.

Regional and global sea-surface temperatures during the last interglaciation.

Hoffman JS, Clark PU, Parnell AC, He F.

Science. 2017 Jan 20;355(6322):276-279. doi: 10.1126/science.aai8464.

PMID:
28104887
3.

A phase 2 study of alisertib (MLN8237) in recurrent or persistent uterine leiomyosarcoma: An NRG Oncology/Gynecologic Oncology Group study 0231D.

Hyman DM, Sill MW, Lankes HA, Piekarz R, Shahin MS, Ridgway MR, Backes F, Tenney ME, Mathews CA, Hoffman JS, Aghajanian C, Hensley ML.

Gynecol Oncol. 2017 Jan;144(1):96-100. doi: 10.1016/j.ygyno.2016.10.036. Epub 2016 Oct 27.

4.

Second Curettage for Low-Risk Nonmetastatic Gestational Trophoblastic Neoplasia.

Osborne RJ, Filiaci VL, Schink JC, Mannel RS, Behbakht K, Hoffman JS, Spirtos NM, Chan JK, Tidy JA, Miller DS.

Obstet Gynecol. 2016 Sep;128(3):535-42. doi: 10.1097/AOG.0000000000001554.

5.

A phase I study of IV doxorubicin plus intraperitoneal (IP) paclitaxel and IV or IP cisplatin in endometrial cancer patients at high risk for peritoneal failure (GOG 9920): an NRG Oncology/Gynecologic Oncology Group study.

McMeekin DS, Sill MW, Walker JL, Moore KN, Waggoner SE, Thaker PH, Rizack T, Hoffman JS, Fracasso PM.

Gynecol Oncol. 2015 Jul;138(1):36-40. doi: 10.1016/j.ygyno.2015.04.038. Epub 2015 May 6.

6.

A phase II trial of brivanib in recurrent or persistent endometrial cancer: an NRG Oncology/Gynecologic Oncology Group Study.

Powell MA, Sill MW, Goodfellow PJ, Benbrook DM, Lankes HA, Leslie KK, Jeske Y, Mannel RS, Spillman MA, Lee PS, Hoffman JS, McMeekin DS, Pollock PM.

Gynecol Oncol. 2014 Oct;135(1):38-43. doi: 10.1016/j.ygyno.2014.07.083. Epub 2014 Jul 11.

7.

A phase II evaluation of aflibercept in the treatment of recurrent or persistent endometrial cancer: a Gynecologic Oncology Group study.

Coleman RL, Sill MW, Lankes HA, Fader AN, Finkler NJ, Hoffman JS, Rose PG, Sutton GP, Drescher CW, McMeekin DS, Hu W, Deavers M, Godwin AK, Alpaugh RK, Sood AK.

Gynecol Oncol. 2012 Dec;127(3):538-43. doi: 10.1016/j.ygyno.2012.08.020. Epub 2012 Aug 23. Erratum in: Gynecol Oncol. 2013 Jul;130(1):252-3.

8.

Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers.

Ramus SJ, Antoniou AC, Kuchenbaecker KB, Soucy P, Beesley J, Chen X, McGuffog L, Sinilnikova OM, Healey S, Barrowdale D, Lee A, Thomassen M, Gerdes AM, Kruse TA, Jensen UB, Skytte AB, Caligo MA, Liljegren A, Lindblom A, Olsson H, Kristoffersson U, Stenmark-Askmalm M, Melin B; SWE-BRCA, Domchek SM, Nathanson KL, Rebbeck TR, Jakubowska A, Lubinski J, Jaworska K, Durda K, Złowocka E, Gronwald J, Huzarski T, Byrski T, Cybulski C, Toloczko-Grabarek A, Osorio A, Benitez J, Duran M, Tejada MI, Hamann U, Rookus M, van Leeuwen FE, Aalfs CM, Meijers-Heijboer HE, van Asperen CJ, van Roozendaal KE, Hoogerbrugge N, Collée JM, Kriege M, van der Luijt RB; HEBON; EMBRACE, Peock S, Frost D, Ellis SD, Platte R, Fineberg E, Evans DG, Lalloo F, Jacobs C, Eeles R, Adlard J, Davidson R, Eccles D, Cole T, Cook J, Paterson J, Douglas F, Brewer C, Hodgson S, Morrison PJ, Walker L, Porteous ME, Kennedy MJ, Pathak H, Godwin AK, Stoppa-Lyonnet D, Caux-Moncoutier V, de Pauw A, Gauthier-Villars M, Mazoyer S, Léoné M, Calender A, Lasset C, Bonadona V, Hardouin A, Berthet P, Bignon YJ, Uhrhammer N, Faivre L, Loustalot C; GEMO, Buys S, Daly M, Miron A, Terry MB, Chung WK, John EM, Southey M, Goldgar D, Singer CF, Tea MK, Pfeiler G, Fink-Retter A, Hansen Tv, Ejlertsen B, Johannsson OT, Offit K, Kirchhoff T, Gaudet MM, Vijai J, Robson M, Piedmonte M, Phillips KA, Van Le L, Hoffman JS, Ewart Toland A, Montagna M, Tognazzo S, Imyanitov E, Issacs C, Janavicius R, Lazaro C, Blanco I, Tornero E, Navarro M, Moysich KB, Karlan BY, Gross J, Olah E, Vaszko T, Teo SH, Ganz PA, Beattie MS, Dorfling CM, van Rensburg EJ, Diez O, Kwong A, Schmutzler RK, Wappenschmidt B, Engel C, Meindl A, Ditsch N, Arnold N, Heidemann S, Niederacher D, Preisler-Adams S, Gadzicki D, Varon-Mateeva R, Deissler H, Gehrig A, Sutter C, Kast K, Fiebig B, Schäfer D, Caldes T, de la Hoya M, Nevanlinna H, Aittomäki K, Plante M, Spurdle AB; kConFab, Neuhausen SL, Ding YC, Wang X, Lindor N, Fredericksen Z, Pankratz VS, Peterlongo P, Manoukian S, Peissel B, Zaffaroni D, Bonanni B, Bernard L, Dolcetti R, Papi L, Ottini L, Radice P, Greene MH, Mai PL, Andrulis IL, Glendon G, Ozcelik H; OCGN, Pharoah PD, Gayther SA, Simard J, Easton DF, Couch FJ, Chenevix-Trench G; Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).

Hum Mutat. 2012 Apr;33(4):690-702. doi: 10.1002/humu.22025. Epub 2012 Feb 14.

9.

A phase II evaluation of nanoparticle, albumin-bound (nab) paclitaxel in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer: a Gynecologic Oncology Group study.

Coleman RL, Brady WE, McMeekin DS, Rose PG, Soper JT, Lentz SS, Hoffman JS, Shahin MS.

Gynecol Oncol. 2011 Jul;122(1):111-5. doi: 10.1016/j.ygyno.2011.03.036. Epub 2011 Apr 15.

10.

A phase II study of gemcitabine (gemzar, LY188011) in the treatment of recurrent or persistent endometrial carcinoma: a gynecologic oncology group study.

Tait DL, Blessing JA, Hoffman JS, Moore KN, Spirtos NM, Lachance JA, Rotmensch J, Miller DS.

Gynecol Oncol. 2011 Apr;121(1):118-21. doi: 10.1016/j.ygyno.2010.11.027. Epub 2010 Dec 14.

PMID:
21159366
11.

Efficacy and safety of imatinib mesylate (Gleevec) and immunohistochemical expression of c-Kit and PDGFR-beta in a Gynecologic Oncology Group Phase Il Trial in women with recurrent or persistent carcinosarcomas of the uterus.

Huh WK, Sill MW, Darcy KM, Elias KM, Hoffman JS, Boggess JF, Alvarez RD, Long HJ, O'Malley DM, Birrer MJ.

Gynecol Oncol. 2010 May;117(2):248-54. doi: 10.1016/j.ygyno.2010.01.002. Epub 2010 Feb 26.

PMID:
20189232
12.

A phase II evaluation of mifepristone in the treatment of recurrent or persistent epithelial ovarian, fallopian or primary peritoneal cancer: a gynecologic oncology group study.

Rocereto TF, Brady WE, Shahin MS, Hoffman JS, Small L, Rotmensch J, Mannel RS.

Gynecol Oncol. 2010 Mar;116(3):332-4. doi: 10.1016/j.ygyno.2009.10.071. Epub 2009 Nov 17. Erratum in: Gynecol Oncol. 2010 Aug 1;118(2):208.

PMID:
19922989
13.

A Phase II evaluation of weekly topotecan as a single agent second line therapy in persistent or recurrent carcinoma of the cervix: a Gynecologic Oncology Group study.

Fiorica JV, Blessing JA, Puneky LV, Secord AA, Hoffman JS, Yamada SD, Buekers TE, Bell J, Schilder JM; Gynecologic Oncology Group.

Gynecol Oncol. 2009 Nov;115(2):285-9. doi: 10.1016/j.ygyno.2009.07.024. Epub 2009 Sep 2.

PMID:
19726073
14.

A phase II study of vorinostat in the treatment of persistent or recurrent epithelial ovarian or primary peritoneal carcinoma: a Gynecologic Oncology Group study.

Modesitt SC, Sill M, Hoffman JS, Bender DP; Gynecologic Oncology Group.

Gynecol Oncol. 2008 May;109(2):182-6. doi: 10.1016/j.ygyno.2008.01.009. Epub 2008 Mar 4.

PMID:
18295319
15.

Cetuximab potentiates oxaliplatin cytotoxic effect through a defect in NER and DNA replication initiation.

Balin-Gauthier D, Delord JP, Pillaire MJ, Rochaix P, Hoffman JS, Bugat R, Cazaux C, Canal P, Allal BC.

Br J Cancer. 2008 Jan 15;98(1):120-8. doi: 10.1038/sj.bjc.6604134. Epub 2008 Jan 8.

16.

Treatment of Helicobacter pylori.

Hoffman JS, Cave DR.

Curr Opin Gastroenterol. 2001 Jan;17(1):30-4.

PMID:
17031146
17.

Suicide among Guaraní Kaiowá and Nandeva youth in Mato Grosso do Sul, Brazil.

Coloma C, Hoffman JS, Crosby A.

Arch Suicide Res. 2006;10(2):191-207.

PMID:
16574616
18.

World Health Organization's TEACH-VIP: contributing to capacity building for youth violence prevention.

Meddings DR, Knox LM, Maddaleno M, Concha-Eastman A, Hoffman JS.

Am J Prev Med. 2005 Dec;29(5 Suppl 2):259-65.

PMID:
16376728
19.

Training health professionals in youth violence prevention: overview of extant efforts.

Sege RD, Hoffman JS.

Am J Prev Med. 2005 Dec;29(5 Suppl 2):175-81. No abstract available.

PMID:
16376713
20.

September 11th anniversary: revisiting the damage beyond Ground Zero.

Chan DS, Callahan CW, Hoffman JS.

Ann Pharmacother. 2004 Nov;38(11):1967. Epub 2004 Oct 12. No abstract available.

PMID:
15479771
21.

Multifocal polypoid endometriosis presenting as huge pelvic masses causing deep vein thrombosis.

Laird LA, Hoffman JS, Omrani A.

Arch Pathol Lab Med. 2004 May;128(5):561-4.

PMID:
15086302
22.

Phase II study of oxaliplatin in platinum-resistant and refractory ovarian cancer: a gynecologic group study.

Fracasso PM, Blessing JA, Morgan MA, Sood AK, Hoffman JS.

J Clin Oncol. 2003 Aug 1;21(15):2856-9.

PMID:
12885801
23.

Separation and capture of CO2 from large stationary sources and sequestration in geological formations--coalbeds and deep saline aquifers.

White CM, Strazisar BR, Granite EJ, Hoffman JS, Pennline HW; Air & Waste Management Association.

J Air Waste Manag Assoc. 2003 Jun;53(6):645-715. Review.

PMID:
12828330
24.

Olfactory discrimination learning deficit in heterozygous reeler mice.

Larson J, Hoffman JS, Guidotti A, Costa E.

Brain Res. 2003 May 2;971(1):40-6.

PMID:
12691835
25.

Term delivery following conservative treatment for villoglandular papillary adenocarcinoma of the uterine cervix: report of a case and analysis of the literature.

Hoffman JS, Bazzurini L, Laird L, Murphy JC, Magriples U, Lewis J.

Gynecol Oncol. 2001 May;81(2):310-3. Review.

PMID:
11330967
26.

In vitro fertilization following conservative management of stage 3 serous borderline tumor of the ovary.

Hoffman JS, Laird L, Benadiva C, Dreiss R.

Gynecol Oncol. 1999 Sep;74(3):515-8.

PMID:
10479523
28.

Pharmacological therapy of Helicobacter pylori infection.

Hoffman JS.

Semin Gastrointest Dis. 1997 Jul;8(3):156-63.

PMID:
9232728
29.

Vector potential of houseflies (Musca domestica) for Helicobacter pylori.

Grübel P, Hoffman JS, Chong FK, Burstein NA, Mepani C, Cave DR.

J Clin Microbiol. 1997 Jun;35(6):1300-3.

30.
31.

Management of Helicobacter pylori infection in ulcer disease.

Cave DR, Hoffman JS.

Hosp Pract (1995). 1996 Jan 15;31(1):63-4, 67-9, 73-5.

PMID:
8595991
32.

Rabbit and ferret parietal cell inhibition by Helicobacter species.

Hoffman JS, King WW, Fox JG, Janik D, Cave DR.

Dig Dis Sci. 1995 Jan;40(1):147-52.

PMID:
7529671
33.

Changes in cell cycle-associated gene expression in a model of impaired liver regeneration.

Albrecht JH, Hoffman JS, Kren BT, Steer CJ.

FEBS Lett. 1994 Jun 27;347(2-3):157-62.

34.

Grand mal seizures associated with the use of fluoxetine.

Levine R, Kenin M, Hoffman JS, Day-Knepple E.

J Clin Psychopharmacol. 1994 Apr;14(2):145-6. No abstract available.

PMID:
8195457
35.

Intra-operative enteroscopy with a sonde intestinal fiberscope.

Hoffman JS, Cave DR, Birkett D.

Gastrointest Endosc. 1994 Mar-Apr;40(2 Pt 1):229-30. No abstract available.

PMID:
8013829
36.

Cyclin and cyclin-dependent kinase 1 mRNA expression in models of regenerating liver and human liver diseases.

Albrecht JH, Hoffman JS, Kren BT, Steer CJ.

Am J Physiol. 1993 Nov;265(5 Pt 1):G857-64.

PMID:
8238514
37.
38.

Primary biliary carcinoma with metastasis to the ovary.

Lashgari M, Behmaram B, Hoffman JS, Garcia J.

Gynecol Oncol. 1992 Nov;47(2):272-4. Review.

PMID:
1334940
39.
40.

Integrating biologic and psychologic treatment: the need for a unitary model.

Hoffman JS.

Psychiatr Clin North Am. 1990 Jun;13(2):369-72.

PMID:
2352897
41.

Long-term fluoxetine treatment of a large number of obsessive-compulsive patients.

Levine R, Hoffman JS, Knepple ED, Kenin M.

J Clin Psychopharmacol. 1989 Aug;9(4):281-3.

PMID:
2504781
42.

Immature teratoma of the ovary.

Koulos JP, Hoffman JS, Steinhoff MM.

Gynecol Oncol. 1989 Jul;34(1):46-9.

PMID:
2737525
43.

Tolerance during long-term administration of intrathecal morphine.

Ali NM, Hoffman JS.

Conn Med. 1989 May;53(5):266-8.

PMID:
2736913
44.

Dysgerminoma: a study of 13 cases from the Connecticut Tumor Registry.

Koulos JP, Hoffman JS.

Conn Med. 1989 Apr;53(4):207-9.

PMID:
2743762
45.

Molar pregnancy coexisting with a normal fetus: a case report.

Deaton JL, Hoffman JS, Saal H, Allred C, Koulos JP.

Gynecol Oncol. 1989 Mar;32(3):394-7.

PMID:
2920964
46.

Percutaneous epidural catheterization for intractable pain in terminal cancer patients.

Ali NM, Hanna N, Hoffman JS.

Gynecol Oncol. 1989 Jan;32(1):22-5.

PMID:
2909444
47.

Housing instability and homelessness among aftercare patients of an urban state hospital.

Drake RE, Wallach MA, Hoffman JS.

Hosp Community Psychiatry. 1989 Jan;40(1):46-51.

PMID:
2536352
48.

Late brain recurrence of choriocarcinoma.

Koulos JP, Hoffman JS.

Gynecol Oncol. 1988 Nov;31(3):467-73. No abstract available.

PMID:
2460396
49.

Enhanced mutagenesis during post-treatment incubation of Escherichia coli treated with cis-diamminedichloroplatinum(II).

Razaka H, Villani G, Hoffman JS, Defais M, Johnson NP.

Mutat Res. 1988 Sep-Oct;209(1-2):63-6.

PMID:
3140004
50.

Central nervous system lesions and advanced ovarian cancer.

Hoffman JS, Pena YM.

Gynecol Oncol. 1988 May;30(1):87-97.

PMID:
3366397

Supplemental Content

Loading ...
Support Center